Endovascular photodynamic therapy with aminolaevulinic acid prevents balloon induced intimal hyperplasia and constrictive remodelling

European Journal of Vascular and Endovascular Surgery

Volumn 24, Issue 4, 2002, Pages 322-331

  Gabeler, E E E ^a   Van Hillegersberg, R ^a   Statius Van Eps, R G ^a   Sluiter, W ^a   Mulder, P ^a   Van Urk, H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ALA; Cholinergic innervation; Endovascular PDT; IH; Light dosimetry; Remodelling; Stenosis model

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON; BLOOD VESSEL WALL; CONTROLLED STUDY; ILIAC ARTERY; NONHUMAN; PARASYMPATHETIC INNERVATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; RESTENOSIS; TREATMENT OUTCOME; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; HYPERPLASIA; INTIMA; MALE; PATHOLOGY; PHOTOCHEMOTHERAPY; RANDOMIZATION; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME; WISTAR RAT;

AMINOLEVULINIC ACID; ANGIOPLASTY, BALLOON; ANIMALS; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERPLASIA; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS; TUNICA INTIMA;

EID: 0036779759     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1723     Document Type: Article

References (46)

1. CURRIER JW, FAXON DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? (editorial). J Am Coll Cardiol 1995; 25: 516-520.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
3. BAUTERS C, MEURICE T, HAMON M, MCFADDEN E, LABLANCHE JM, BERTRAND ME. Mechanisms and prevention of restenosis: from experimental models to clinical practice. Cardiovasc Res 1996; 31: 835-846.
4. GUZMAN LA, MICK MJ, ARNOLD AM, FORUDI F, WHITLOW PL. Role of intimal hyperplasia and arterial remodeling after balloon angioplasty: an experimental study in the atherosclerotic rabbit model. Arterioscler Thromb Vasc Biol 1996; 16: 479-487.
5. WILLIAMS B. Mechanical influences on vascular smooth muscle cell function. J Hypertens 1998; 16: 1921-1929.
6. CLOWES AW, REIDY ME, CLOWES MM. Kinetics of cellular proliferation after arterial injury; 1. Smooth muscle growth in the absence of endothelium. Laboratory Investigation 1983; 49: 327-333.
7. CHEN JC, HSIANG YN, BUCHAN AM. Somatostatin receptor expression in rat iliac arteries after balloon injury. J Invest Surg 1997; 10: 17-23.
8. GILAD GM, KAGAN HM, GILAD VH. Lysyl oxidase, the extracellular matrix forming enzyme in rat brain injury sites. Neuroscience Letters 2001; 310: 45-48.
9. HILTUNEN JO, LAURIKAINEN A, AIRAKSINEN MS, SAARMA M. GDNF family receptors in the embryonic and postnatal rat heart and reduced cholinergic innervation in mice hearts lacking Ret or GFRa2. Dev Dynamics 2000; 219: 28-39.
10. LEE JHM, PEULER JD. A possible indirect sympathomimetic action of metformin in the arterial vessel wall of spontanously hypertensive rats. Life Sciences 2001; 69: 1085-1092.
11. LINDAUER U, KUNZ A, SCHUH-HOFER S, VOGT J, DREIER JP, DIRNAGL U. Nitric oxide from perivascular nerves modulates cerebral arterial pH reactivity. Am J Physiol Heart Circ Phys 2001; 281: H1353-H1363.
12. MILNER P, LOESCH A, BURNSTOCK G. Neural endothelin in hypertension:increased expression in ganglia and nerves to cerebral arteries of the spontaneously hypertensive rat. J Vasc Res 2000; 37: 39-49.
13. MONAHAN KD, TANAKA H, DINENNO FA, SEALS DR. Central arterial compliance is associated with age- and habitual exercise-related differences in cardiovagal baroreflex sensitivity. Circulation 2001; 104: 1627-1632.
14. SPILKER MH, ASANO K, YANNAS IV, SPECTOR M. Contraction of collagen-glycosaminoglycan matrices by peripheral nerve cells in vitro. Biomaterials 2001; 22: 1085-1093.
15. TSUCHIDA A, HANDA Y, NOJYO Y, KUBOTA T. Ultrastructure of NADPH diaphorase-positive nerve fibres and their terminals in the rat cerebral arterial system. J Chem Neuroanatomy 2001; 21: 267-275.
16. HERRMAN JP, HERMANS WR, Vos J, SERRUYS PW. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I). Drugs 1993; 46: 18-52.
17. CASTRONUOVO JJ, JR, Guss SB, MYSH D, SAWHNEY A, WOLFF M, GOWN AM. Cytokine therapy for arterial restenosis: inhibition of neointimal hyperplasia by gamma-interferon. Cardiovasc Surg 1995; 3: 463-468.
18. ERIKSEN UH, AMTORP O, BAGGER JP, EMANUELSSON H, FOEGH M, HENNINGSEN P et al. Randomised double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am Heart J 1995; 130: 1-8.
19. FELDMAN LJ, TAHLIL O, STEG PG. Adenovirus-mediated arterial gene therapy for restenosis: problems and perspectives. Semin Interv Cardiol 1996; 1: 203-208.
20. KALINOWSKI M, TEPE G, SCHIEBER A, BREHME U, BRUCK B, ERLEY CM et al. Local administration of ramiprilat is less effective than oral ramipril in preventing restenosis after balloon angioplasty in an animal model. J Vasc Interv Radiol 1999; 10: 1397-1404.
21. MIYAUCHI K, KAWAI S, OKADA R, YAMAGUCHI H. Limitations of angiotensin-converting enzyme inhibitor in restenosis of a deep arterial injury model. Jpn Circ J 1998; 62: 53-60.
22. MIYAZAWA N, UMEMURA K, RONDO K, NAKASHIMA M, STEG PG, TAHLIL O et al. Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat J Cardiovasc Pharmacol 1997; 30: 157-162.
23. OHSAWA H, NOIKE H, KANAI M, YOSHINUMA M, MINEOKA K, HITSUMOTO T et al. Preventive effects of an antiallergic drug, pemirolast potassium, on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1998; 136: 1081-1087.
24. Wu KK. Prostacyclin and nitric oxide-related gene transfer in preventing arterial thrombosis and restenosis. Agents Actions Suppl 1997; 48: 107-123.
25. TEIRSTEIN PS, MASSULLO V, JANI S, POPMA JJ, Russo RJ, SCHATZ RA et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial (see comments). Circulation 2000; 101: 360-365.
26. VERIN V, POPOWSKI Y. Intraarterial beta irradiation to reduce restenosis after PTCA. Experimental and clinical experience. Herz 1998; 23: 347-355.
27. STRECKER EP, GABELMANN A, Boos I, LUCAS C, Xu Z, HABERSTROH J et al. Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries. Cardiovasc Intervent Radiol 1998; 21: 487-496.
28. MEHRAN R, DANGAS G, ABIZAID AS, MINTZ GS, LANSKY AJ, SATLER LF et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878.
29. HENDERSON BW, DOUGHERTY TJ. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145-157.
30. LAMURAGLIA GM, ORTU P, FLOTTE TJ, ROBERTS WG, SCHOMACKER KT, CHANDRASEKAR NR et al. Chloroaluminum sulfonated phthalocyanine partitioning in normal and intimal hyperplastic artery in the rat. Implications for photodynamic therapy. Am J Pathol 1993; 142: 1898-1905.
31. NYAMEKYE I, ANGLIN S, MCEWAN J, MACROBERT A, BOWN S, BISHOP C. Photodynamic therapy of normal and balloon-injured rat carotid arteries using 5-amino-levulinic acid. Circulation 1995; 91: 417-425.
32. ORTU P, LAMURAGLIA GM, ROBERTS WG, FLOTTE TJ, HASAN T. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. Circulation 1992; 85: 1189-1196.
33. GRANT WE, SPEIGHT PM, MACROBERT AJ, HOPPER C, BOWN SG. Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Caner 1994; 70: 72-78.
34. ROCKSON SG, LORENZ DP, CHEONG WF, WOODBURN KW Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy. Circulation 2000; 102: 591-596.
35. JENKINS MP, BUONACCORSI GA, RAPHAEL M, NYAMEKYE I, McEwAN JR, BOWN SG et al. Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty. Br J Surg 1999; 86: 1258-1263.
36. HEISTERKAMP J, HILLEGERSBERG VAN R, SINOFSKY E, IJZERMANS J. Heat resistant cylindrical diffuser for interstitial laser coagulation: Comparison with a bare-tip fibre in ex vivo porcine liver. Lasers Surg Med 1997; 20: 304-309.
37. INDOLFI C, CIOPPA A, STABILE, E. DI LORENZO E, ESPOSITO G, PISANI A et al. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol 2000; 35: 214-221.
38. VAN DEN BOOGERT J, VAN HILLEGERSBERG R, VAN STAVEREN HJ, DE BRUIN RW, VAN DEKKEN H, SIERSEMA PD et al. Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus. Br J Cancer 1999; 79: 825-830.
39. POST MJ, BORST C, KUNTZ RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig (see comments). Circulation 1994; 89: 2816-2821.
40. OVERHAUS M, HECKENKAMP J, KOSSODO S, LESZCZYNSKI D, LAMURAGLIA GM. Photodynamic therapy generates a matrix barrier to invasive vascular cell migration. Circ Res 2000; 86: 334-340.
41. FURCHGOTT RF, ZAWADSKI JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by achetylcholine. Nature 1980; 288: 373-376.
42. STATIUS VAN EPS RG, CHANDRASEKAR NR, HASAN T, LAMURAGLIA GM. Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia. Photochem Photobiol 1998; 67: 337-342.
43. GRANT WE, SPEIGHT PM, MACROBERT AJ, HOPPER C, BOWN SG. Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer 1994; 70: 72-78.
44. NYAMEKYE I, ANGLIN S, MCEWAN J, MACROBERT A, BOWN S, BISHOP C. Photodynamic therapy of normal and balloon-injured rat carotid arteries using 5-amino-levulinic acid. Circulation 1995; 91: 417-425.
45. LAMURAGLIA GM, ORTU P, FLOTTE TJ, ROBERTS WG, SCHOMACKER KT, CHANDRA SEKAR NR et al. Chloroaluminum sulfonated phthalocyanine partitioning in normal and intimal hyperplastic artery in the rat. Implications for photodynamic therapy. Am J Pathol 1993; 142: 1898-1905.
46. KIPSHIDZE N, SAHOTA H, KOMOROWSKI R, NIKOLAYCHIK V, KEELAN MH, JR. Photoremodeling of arterial wall reduces restenosis after balloon angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol 1998; 31: 1152-1157.